Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1999
03/31/1999EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
03/31/1999EP0904293A1 An interleukin-5 antagonist
03/31/1999EP0904292A1 Growth differentiation factor-14
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/31/1999EP0904289A1 Candida albicans tata-binding protein, nucleic acid and assays
03/31/1999EP0904288A2 Pathogenic escherichia coli associated protein
03/31/1999EP0904287A2 Cytokine designated lerk-8
03/31/1999EP0904285A1 Cyclic adhesion inhibitors
03/31/1999EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors
03/31/1999EP0904283A1 Human netrin-1
03/31/1999EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
03/31/1999EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
03/31/1999EP0904279A1 Novel tumor suppressor gene, dpc4
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999EP0904277A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
03/31/1999EP0904271A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
03/31/1999EP0904112A1 Composition comprising interleukin-1 inhibitor and controlled release polymer
03/31/1999EP0904108A1 METHODS FOR TREATMENT OF ALLERGIC DISEASES WITH IgE
03/31/1999EP0904107A1 Immunoglobin-like domains with increased half lives
03/31/1999EP0904105A1 Novel compounds
03/31/1999EP0904104A1 Novel compounds
03/31/1999EP0904103A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE GLUTAMYL tRNA SYNTHETASE FAMILY
03/31/1999EP0904102A1 Milk of transgenic animals containing human alpha 1-antitrypsin and use of human alpha 1-antitrypsin to treat bile acid related diseases
03/31/1999EP0904100A1 Receptor ligand-facilitated delivery of biologically active molecules
03/31/1999EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
03/31/1999EP0904098A1 Compositions comprising antifungal agent and acetate buffer
03/31/1999EP0904097A2 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
03/31/1999EP0904096A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation
03/31/1999EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/31/1999EP0904094A1 Treatment of bone disorders with adrenomedullin
03/31/1999EP0904093A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma
03/31/1999EP0904074A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases
03/31/1999EP0904062A2 Sustained release ionic conjugate
03/31/1999EP0904058A1 Pharmaceutical preparation in the form of liposomes
03/31/1999EP0903981A1 Design of novel highly efficient hiv based packaging systems for gene therapy
03/31/1999EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0619119B1 Stabilized parathyroid hormone composition
03/31/1999EP0591378B1 Method of preventing and treating chemotherapy-induced alopecia
03/31/1999EP0567514B1 A system for enhanced in-vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion of agents
03/31/1999CN1212706A Serine protease inhibitors
03/31/1999CN1212705A Serine protease inhibitors
03/31/1999CN1212704A Serine protease inhibitors
03/31/1999CN1212703A Chromatographic process for obtaining very pure cycloporin A and related cyclosporins
03/31/1999CN1212628A Method of promoting bone growth with hyaluronic acid and growth factors
03/31/1999CN1212605A Composition and its use as food supplement or for lowering lipids in serum
03/31/1999CN1212163A Smoking health-care product
03/31/1999CN1212150A Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in blood to reduce risk of athereosclerosis and vascular disease
03/30/1999US5889177 Melatonin 1A receptor gene regulatory regions and uses thereof
03/30/1999US5889175 Nucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replication
03/30/1999US5889173 DNA encoding multifunctional neurothrophic factors
03/30/1999US5889171 Genetic engineered polypeptide
03/30/1999US5889170 Human integral membrane protein
03/30/1999US5889168 Fusion glycoprotein from HCMV and HSV
03/30/1999US5889166 Recombinant neospora antigens and their uses
03/30/1999US5889160 Human IL-2 receptor γ-chain molecule antibody
03/30/1999US5889159 Monoclonal antibodies to tumor marker TC1 and methods for use of same
03/30/1999US5889158 Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens
03/30/1999US5889157 Humanized B3 antibody fragments, fusion proteins, and uses thereof
03/30/1999US5889156 TNF deletion muteins
03/30/1999US5889153 Protein or polypeptide, method for producing the same and intermediate compound therefor
03/30/1999US5889150 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target protiens
03/30/1999US5889149 Purified PDGF AB isoform and method of making it
03/30/1999US5889148 Antibiotic peptides
03/30/1999US5889147 Bromo-tryptophan conopeptides
03/30/1999US5889145 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889110 Sustained release preparations
03/30/1999US5888992 Polar substituted hydrocarbons
03/30/1999US5888990 Phosphocholine drug derivatives
03/30/1999US5888988 Wound healing agent
03/30/1999US5888983 Inserting dna, rna into cells to repair genetic disorders
03/30/1999US5888982 Regulation of vascular smooth muscle cell heme oxygenase-1
03/30/1999US5888980 Compositions for enhancing immune function
03/30/1999US5888978 Method for reducing the severity of gastro-intestinal damage
03/30/1999US5888977 Therapeutic uses of BPI protein products for human meningococcemia
03/30/1999US5888976 Bacillus thuringiensis toxin for pest control
03/30/1999US5888974 Genetic engineered polypeptide; blood coagulation
03/30/1999US5888973 Administering bactericidal/permeability-increasing protein to treat coronary artery disease
03/30/1999US5888972 Endothelin antagonist
03/30/1999US5888971 Macrocyclic peptides useful in the treatment of thrombin related disorders
03/30/1999US5888969 Crohn*s disease
03/30/1999US5888967 Administering urokinases, tissue plasminogen activator andstreptokinase
03/30/1999US5888965 Method of stimulating bone marrow regeneration
03/30/1999US5888964 Method for increasing placental blood flow
03/30/1999US5888963 Treatment of bone disorders with adrenomedullin
03/30/1999US5888817 For breast and prostate cancer cells
03/30/1999US5888812 Myeloid cell leukemia associated gene MCL-1
03/30/1999US5888810 Antigenic fusion protein useful for decreasing colonization in chickens
03/30/1999US5888808 Bacterial polypeptide expression employing tryptophan promoter-operator
03/30/1999US5888793 Human lysophosphatidic acid acyltransferase
03/30/1999US5888792 Encoded with polynucleotide sequence
03/30/1999US5888775 Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof
03/30/1999US5888773 Genetic engineered protein
03/30/1999US5888772 Amino acid sequences of mutants with higher biological activity; for treatment of anemia and induction of erythropoiesis
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888765 Endothelial-cell specific promoter
03/30/1999US5888764 Human fas gene promoter region
03/30/1999US5888763 Polypeptide
03/30/1999US5888762 Neurotropic growth factors comprising a homeobox peptide
1 ... 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 ... 3163